Conference call (FDA approval of JYNNEOS)

September 25, 2019 | Investor

The management of Bavarian Nordic held a conference call on September 25, 2019 to discuss the FDA approval of JYNNEOS.

A listen-only version of the call with presentation slides and the Q&A session is available on-demand via the link below.